The Nova Scotia Take Home Naloxone Program. Amanda Hudson-Frigault, MA NS THN Coordinator
|
|
- Gyles Armstrong
- 6 years ago
- Views:
Transcription
1 The Nova Scotia Take Home Naloxone Program Amanda Hudson-Frigault, MA NS THN Coordinator
2 Who are the Health Promoters in your Neighborhood?
3 Background The misuse of opioids has become a leading health and safety concern in Nova Scotia, Canada and in other developed nations. Opioid misuse poses risks, harms and injuries to individuals, families and communities including increased risk for overdose and death. The rate of acute opioid toxicity mortality in the province has remained relatively stable at approximately 60 deaths per year (rate ~6 deaths/100,000 population, closed cases) 1. Between the years , there have been 303 acute opioid toxicity deaths in Nova Scotia. 1 There were 53 confirmed acute opioid toxicity deaths in There have been 39 confirmed and 11 probable opioid toxicity deaths in 2017 (as of the end of October 2017.) 1 * 1. NS Medical Examiner Service *Important-Numbers are subject to change as probable cases are confirmed or excluded and cases are added; many case investigations are ongoing).
4 Background In September 2015, DHW approved one-time grants to fund two opioid overdose prevention demonstration projects. The first is led by Direction 180, in partnership with Mainline Needle Exchange, and targets people at risk for opioid overdose in the HRM. The second is led by NSHA s Mental Health and Addictions, in partnership with the Ally Centre of Cape Breton, and targets people at risk for opioid overdose in the Cape Breton area. 4 staff from the demonstration project sites travelled to Toronto to The Point Program for training. The demonstration project sites adapted The Point s medical directive and training materials (with permission) for the Nova Scotia context.
5 Background The demonstration projects were scheduled to end in September MHA decided to fund an extension of the two demonstration projects until March 31, 2017 to allow time to explore a provincial framework and sustainable funding for opioid overdose prevention. As of September 2017, over 1500 kits have been disseminated in communities and there have been at least 60 reported opioid overdose reversals, as a result of this project.
6 Pharmacy Program In September 2017, the Community Pharmacy phase of the program was launched Opioid overdose prevention training and take home Naloxone kits became available without a prescription, free of charge, for those participants who are eligible. As of November 2017, 259 pharmacies are participating in the program.
7 Evidence to Support THN Programs Over the last 16 years, international evidence shows that provision of Take Home Naloxone (THN) programs, with appropriate training (to peers, family members and outreach workers) was remarkably safe with few, if any, adverse effects. None of the major concerns about THN have been borne out to date. 1 (such as unsafe naloxone administration, problems with re-intoxication when longer-acting opioids have been used, harm to overdose victims or those around them) There has been no evidence of THN leading to more drug use. In fact, participants in THN programs have reported a reduction in their drug use. 2,3 Two recent systematic reviews of the evidence from non-randomized studies, show that bystanders when properly trained can and will use naloxone to reverse opioid overdoses. 4,5 Training is effective in increasing the knowledge of, and positive attitudes towards, the correct use of naloxone, and overdose management. 6
8 Other THN Programs Take Home Naloxone Programs exist in several provinces, such as British Columbia, Alberta, Manitoba, Ontario, Quebec, Newfoundland and Labrador and Yukon. In Saskatchewan, New Brunswick and Prince Edward Islandnaloxone kits are available at pharmacies NS THN Program has adapted materials from Toronto s The Point Program, BC s Toward the Heart Program and Alberta Health Services Take Home Naloxone Program
9 Who should Receive a Naloxone Kit? Naloxone should only be provided to participants for whom naloxone is indicated, such as individuals who meet the following four criteria: 1) a) are at risk for opioid overdose; or b) are likely to witness and respond to an overdose such as family, friends and those who work with individuals who are at risk of opioid overdose 2) Have no known contraindications to naloxone as described in product monograph (Naloxone is contraindicated in patients known to be hypersensitive to it.) 3) Have provided informed consent to receive a THN kit (Consent to provision of THN kit is achieved expressly or implicitly when the Participant finishes the Program s training and willfully accepts their THN kit). 4) Have completed the Program s opioid overdose prevention/naloxone administration training.
10 Priority Populations. NS s THN program will prioritize the following high risk groups: Individuals who may have a opioid use disorder and who are not in treatment, including those who are on wait lists for treatment or not actively seeking treatment; Individuals who use opioids, including methadone, with known or suspected use of alcohol or benzodiazepines, or other drugs known to increase overdose risk; Higher-risk patients on opioid agonist therapy including patients who are about to start methadone or buprenorphine/naloxone treatment for opioid use disorder or in the first two months of treatment; Individuals with previous opioid-associated overdose including those with one or more previous: unintentional overdoses involving opioids (accidental overdoses) or intentional overdoses involving opioids (suicide attempts by overdose); and Individuals who have stopped using opioids, but are at high risk for relapse*.
11 What is in a THN Kit?
12 5 Overdose Response Steps: Step 1. Stimulation (Shake at shoulders & Shout their name). Step 2. Call 911. Place phone on speaker to receive additional support and instructions. Step 3. Inject Naloxone. 1 ampoule (0.4mg/ml) into muscle (upper arm or upper thigh). Step 4. Start Chest Compressions or full CPR and/or rescue breathing as trained. Use AED if one is available. Step 5. Is it Working-If there is no improvement in 3-5 minutes repeat steps 3 & 4. Stay! Stick around until EHS arrives. Note: Participants are shown how to perform chest compressions and how to use the one-way breathing barrier. Upon completion of the training, the instructor will assess and ensure the participant s understanding through verbal recall and accurate demonstration of their competency in naloxone administration. *These five steps have been adapted from the POINT program, Toronto.
13 Good Samaritan Act for Drug Overdose In May 2017, a new law was passed in Canada: It provides protection for both the drug overdose victim and the person phoning 911 from: 1. Simple possession 2. Parole violations 3. Pre-trial conditions 4. Probation orders 5. Conditional sentences Full Act can be found at;
14 THN Program Website
15 What Supports can Health Promoters offer to Post Secondary Institutions?
16 Questions
17 References 1. Enteen L, Bauer J, McLean R, et al. Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco. J Urban Heal. 2010;87(6): doi: /s Maxwell S. Distributing Naloxone... Because Dead Addicts Never Recover. In: Australian Drugs Conference. Melbourne; 2010: Seal KH, Thawley R, Gee L, et al. Naloxone Distribution and Cardiopulmonary Resuscitation Training for Injection Drug Users to Prevent Heroin Overdose Death: A Pilot Intervention Study. J Urban Heal. 2005;82(2): doi: /jurban/jti Clark AK, Wilder CM, Winstanley EL. A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs. J Addict Med. 2014;8(3): doi: /adm European Monitoring Centre for Drugs and Drug Addiction. Preventing Fatal Overdoses: A Systematic Review of the Effectiveness of Take-Home Naloxone.; Walley AY, Xuan Z, Hackman HH, et al. Opioid Overdose Rates and Implementation of Overdose Education and Nasal Naloxone Distribution in Massachusetts: Interrupted Time Series Analysis. BMJ. 2013;346:f174. doi: /bmj.f174.
Reducing opioid overdose mortality: role of communityadministered
Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)
More informationOpioids and Overdose 2017
Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed
More informationDISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.
DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide
More informationOxyContin in the 90 days prior to it being discontinued.
Appendix 1 (as supplied by the authors): Supplementary data Provincial Drug Insurance program formulary listing status for OxyNeo by province Province Listing of OxyNeo BC Listed for patients covered by
More informationResearch on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.
Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation. Alex H. Kral, PhD Director Behavioral and Urban Health Program RTI
More informationNaloxone (Narcan) Initiatives and the Court System
Naloxone (Narcan) Initiatives and the Court System Jolene Defiore-Hyrmer, Section Chief Violence and Injury Prevention Section 2018 Specialized Docket Conference October 12, 2018 2:45-4:00 Learning Objectives
More informationNaloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition
Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss
More informationONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health
ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Dr. David Williams Chief Medical Officer of Health National opioid-related mortality data, 2016 (Health Canada) Provincial Overdose Coordinator
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
More informationPreventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction
Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction Coalition New York, NY Sleestan@gmail.com Strategies to
More informationWest Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition
and Other Mosquito borne Diseases National Surveillance Report English Edition July to July 8, 17 (Week 7) West Nile Virus Canada Humans As of surveillance week 7, ending on July 8, 17, the Public Health
More informationCommunity Pharmacy Distribution of Naloxone
Community Pharmacy Distribution of Naloxone College of Pharmacists of BC BC Centre for Disease Control Harm Reduction Program Sponsored in part by the BC Ministry of Health What is Naloxone? Naloxone is
More informationPoison Control Centres
Poison Control Centres Monica Durigon Field Epidemiologist Public Health Agency of Canada Joanne Stares Public Health Officer Public Health Agency of Canada Placement site: BC Centre for Disease Control
More informationNaloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no
THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any
More informationFentanyl, Opioid Overdose and Naloxone
Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians
More informationMaryland s Good Samaritan Law
Maryland s Good Samaritan Law Annotated Code of Maryland, Criminal Procedure 1-210 Effective October 1, 2015 1 Maryland Public Opinion Survey (MPOS) Administered online February 20 - March 15, 2015 to
More informationMinister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018
The Minister s Opioid Emergency Response Commission was established May 31, 2017 to support the Government of Alberta s urgent response to the opioid crisis. As part of its mandate, the Commission is responsible
More informationNALOXONE RISK ASSESSMENT
NALOXONE RISK ASSESSMENT Intended audience: Non-public sector organizations. Introduction: BC is currently experiencing a public health emergency related to the unprecedented increase in opioid overdoses
More informationPeer Naloxone. A harm reduction approach to overdose prevention. Kristel Guthrie RN BScN BA. Chantel Marshall RN BScN. The Works Toronto Public Health
Peer Naloxone A harm reduction approach to overdose prevention Kristel Guthrie RN BScN BA Chantel Marshall RN BScN The Works Toronto Public Health November, 2011 Overview of Session Timeline of >POINT
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationImpaired driving statistics
driving statistics Telling Canada s story in numbers Yvan Clermont Canadian Centre for Justice Statistics Standing Senate Committee on Legal and Constitutional Affairs February 8 th, 2018 Key points While
More informationA Conversation on Fentanyl. School District 22 VERNON
A Conversation on Fentanyl School District 22 VERNON Why are we talking about this? In 2016 there were 922 unintentional overdose deaths in British Columbia 158 of those deaths occurred in Interior Health
More informationWORKPLACE SMOKING BAN POLICY
WORKPLACE SMOKING BAN POLICY Introduction: How to Use This Tool Having a smoking policy addresses the hazards of secondhand smoke to the health and well-being of your workforce. In most regions, it is
More informationPhysiotherapists in Canada, 2011 National and Jurisdictional Highlights
pic pic pic Physiotherapists in Canada, 2011 National and Jurisdictional Highlights Spending and Health Workforce Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the
More informationThe Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded
The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded access to naloxone, overdose education, prevention,
More informationMethadone 8.3. Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures.
Methadone 8.3 Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures. Last Updated: February 15, 2010 Table of Contents Methadone Drug and Mixture Card
More informationTake Home Naloxone: Law Update and Considerations for Pharmacy Professionals
Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University
More informationNALOXONE CAN BE A LIFESAVER
NALOXONE 1 CAN BE A LIFESAVER Naloxone is a drug which can temporarily reverse the effects of opioid (heroin/methadone) overdose. In an overdose state, it can be a lifesaver 2 3 what to do IF SOMEONE HAS
More informationMainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders
Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference
More informationPoisoning and Poison Control Centres across Canada
Poisoning and Poison Control Centres across Canada Please click on any of the links below to go directly to your specified topic within this document. When to Call 911 Signs and Symptoms of Poisoning For
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More informationGrampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum)
Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum) This presentation aims to refresh knowledge on the causes, risk
More informationOpioid Harm Reduction
Opioid Harm Reduction Lucas G. Hill, PharmD Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Clinical Pharmacist, CommUnityCare FQHCs Director, Operation Naloxone Mark
More informationNALOXONE CAN BE A LIFESAVER
NALOXONE 1 CAN BE A LIFESAVER Naloxone is a drug which can temporarily reverse the effects of opioid (heroin/methadone) overdose. In an overdose state, it can be a lifesaver 2 3 what to do IF SOMEONE HAS
More informationTake Home Naloxone elearning Module Script
elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide
More informationResponding to BC s Opioid Overdose Epidemic
Responding to BC s Opioid Overdose Epidemic Progress Update September 2017 BACKGROUND Since BC s Public Health Emergency was declared in 2016, people across the province have mobilized to immediately respond
More informationOpioids - Fentanyl - Naloxone. Public Health Nurse
Opioids - Fentanyl - Naloxone Public Health Nurse What are Opioids? Opioids are a family of drugs that treat pain and can cause sleepiness. Prescription (legal) Opioids fall into 3 main categories: 1.
More informationProvincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association
ARTHRITIS COMMUNITY RESEARCH & EVALUATION UNIT (ACREU) The Arthritis and Immune Disorder Research Centre Health Care Research Division University Health Network February, 2000 Provincial Projections of
More informationNALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE
NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE WHAT IT IS WHAT IT IS NARCAN (naloxone HCl) Nasal Spray is the first and only FDA-approved nasal form of naloxone for the emergency treatment of a known
More informationMedical Aid in Dying A Year of Change
Medical Aid in Dying A Year of Change Howard Lim, MD, PhD, FRCPC Chair, Gastrointestinal Tumour Group Program Director, Medical Oncology Residency Training Program Clinical Associate Professor, University
More informationPublic Health Dorset Prenoxad (Naloxone) Supply Standard Operating Procedure (SOP)
Public Health Dorset Prenoxad (Naloxone) Supply Standard Operating Procedure (SOP) 1 Introduction 1.1 Purpose This SOP aims to provide guidance on the supply of take home naloxone, in the form of Prenoxad
More informationBRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS
BRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS For people who inject heroin and other opioids, overdose is an urgent issue. The Global Fund to Fight AIDS, Tuberculosis and Malaria
More informationNaloxone for opioid safety
SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH Naloxone for opioid safety A provider s guide to prescribing naloxone to patients who use opioids 1 NALOXONE FOR OPIOID SAFETY Overdose is the leading cause of
More information1. When are dispensers able to provide publicly funded naloxone emergency kits for Ontarians?
Ontario Public Drug Programs Division Ontario Naloxone Program for Pharmacies (ONPP) Frequently Asked Questions for Pharmacy Dispensers: Providing Publicly Funded Naloxone Kits and Claims Submission Using
More informationABOUT FMC MEMBERSHIP:
ABOUT FMC MEMBERSHIP: FMC and your provincial/territorial association are a part of a network of interdisciplinary professionals made up of private and court connected mediators, lawyers, social workers,
More informationCHAPTER 4: Population-level interventions
CHAPTER 4: Population-level interventions Population-level interventions refer to policies and programs that are applied to entire populations to promote better health outcomes. In this chapter, we describe
More informationcommunity Klimas, Jan; Tobin, Helen; Egan, Mairead; Tomas, Barry; Bury, Gerard International Journal of Drug Policy
General practice A key route for distribution of naloxone in the community Authors Citation DOI Journal Rights Klimas, Jan; Tobin, Helen; Egan, Mairead; Tomas, Barry; Bury, Gerard General practice A key
More information1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care
A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care Michael W. Dailey, MD FACEP Chief, Division of Prehospital and Operational Medicine Associate Professor of
More informationOpiate Overdose Treatment: Naloxone Training Protocol
OREGON STATE PUBLIC HEALTH DIVISION EMS & Trauma Systems Kate Brown, Governor September 22, 2016 For more information, contact David Lehrfeld, MD, Medical Director, EMS & Trauma Systems: (971) 673-0520
More informationTake Home Naloxone: What Pharmacists Need to Know
Take Home Naloxone: What Pharmacists Need to Know Sheri L. Fandrey, BSP, PhD Knowledge Exchange Lead Manitoba Addictions Knowledge Exchange Conflict of Interest/Disclosure Dr. Sheri Fandrey Has no conflicts
More informationMembership Application
Family Mediation Canada / Médiation Familiale Canada Membership Application Family Mediation Canada is an interdisciplinary association of professionals, working together, creating a better way to provide
More informationGood Samaritan. State with this law in place: New Mexico, Washington, New York, Connecticut, Illinois (to be enforced June 1, 2012)
Good Samaritan Immunity Laws that provide protection from prosecution for calling 911 if seeking medical attention for self or another experiencing an overdose The US Conference of Mayors 2008 unanimously
More informationAddressing the Harms of Prescription Drugs in Canada
www.ccsa.ca www.cclt.ca Addressing the Harms of Prescription Drugs in Canada Innovations & Policy Solutions for Addressing Prescription Drug Abuse April 30, 2014 Rita Notarandrea, Canadian Centre on Substance
More informationHealth Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods
ENVIRONMENTAL SCAN Health Interventions in Ambulatory Cancer Care Centres Context Cancer, a complex, chronic condition, will affect an estimated two in five Canadians in their lifetime. 1 Cancer requires
More information6/6/2017. Faculty/Presenter Disclosure. Disclosure of Commercial Support
Opioids in Ontario, Canada: The need to reduce the prescribed opioid load; and need for mass casualty preparation Kieran Moore, Professor of Emergency Medicine, Queen s University, Associate Medical Officer
More informationPROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA. By Kwing Hung, Ph.D. Nathalie L. Quann, M.A.
PROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA By Kwing Hung, Ph.D. Nathalie L. Quann, M.A. Research and Statistics Division Department of Justice Canada February 2000 Highlights From 1977 to 1998,
More informationWest Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 2016 (Week 37)
West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 16 (Week 37) Canada Humans During surveillance week 37, ending on September
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationWe are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada
Programs & services Who we are Active in communities across Canada, the Alzheimer Society provides information, support and education to people living with Alzheimer s disease and other dementias. We are
More informationOpioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationOpioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences
Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry
More informationSubstance Misuse and Abuse
CHAPTER 18 Substance Misuse and Abuse Lesson Objectives 1. Explain actions that can be taken to help prevent youth from abusing drugs and other substances. 2. Describe specific steps for preventing someone
More informationNova Scotia's. Opioid Use and Overdose Framework
Nova Scotia's Opioid Use and Overdose Framework Crown copyright, Province of Nova Scotia, 2017 Nova Scotia s Opioid Use and Overdose Framework Department of Health and Wellness July 2017 ISBN: 978-1-55457-748-4
More informationWEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT
WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT AUG 3 TO SEPT 5, 215 REPORT WEEK 35 CANADA HUMANS During surveillance week 35, ending on Sept 5, 215, three (3 ) human clinical
More informationColorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT
Colorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT JANUARY 2011 DECEMBER 2012 Acknowledgments The Canadian Partnership Against Cancer would like to gratefully
More informationNARCAN: THE HISTORY, APPLICATIONS AND FUTURE
NARCAN: THE HISTORY, APPLICATIONS AND FUTURE TABLE OF CONTENTS 3 Intro 4 What is Naloxone? 8 How Naloxone is Administered 12 Where to Find Narcan in California The United States accounts for about five
More informationHL18.3 REPORT FOR ACTION. Toronto Overdose Action Plan: Prevention & Response SUMMARY
HL18.3 REPORT FOR ACTION Toronto Overdose Action Plan: Prevention & Response Date: March 10, 2017 To: Board of Health From: Acting Medical Officer of Health Wards: All SUMMARY At its meeting of December
More informationNaloxone for Opioid Safety
Naloxone for Opioid Safety Phillip O. Coffin, MD MIA San Francisco Department of Public Health University of California San Francisco Disclosure Information Gilead, Donated ledipasvir-sofosbuvir, Study,
More informationSafe Job Procedure Overdose Prevention Injectable Naloxone
Safe Job Procedure Overdose Prevention Injectable Naloxone Preparation: Safety Specialist Approval Authority: Senior Management Issuing Dept: Safety Industry Type: All Initial Issue Date: August 3, 2018
More informationWest Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 24, 2016 (Week 38)
West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 4, 16 (Week 38) Canada Humans During surveillance week 38, ending on September 4,
More informationTemple University Beasley School of Law. Project on Harm Reduction in the Health Care System
Temple University Beasley School of Law Project on Harm Reduction in the Health Care System DATE: January 8, 2008 MEMORANDUM RE: The legal requirements for operating an Opioid Antagonist Administration
More informationWEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT
WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT OCT 4 TO OCT 1, 215 REPORT WEEK 4 CANADA HUMANS During surveillance week 4, ending on Oct.1, 215, six (6) human clinical cases
More informationOptimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial
Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial J. Tinmouth, N.N. Baxter, L.F. Paszat, E. Randell, M. Serenity, R. Sutradhar, L. Rabeneck Conflicts of
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationOccupational Noise Exposure
Occupational Noise Exposure Tim Kelsall CIH, ROH Director Noise and Vibration Hatch - Consulting Engineers tkelsall@hatch.ca 1 Noise Induced Hearing Loss > one million adults across the country reported
More informationMethadone/Buprenorphine 101
Methadone/Buprenorphine 101 October 1, 2016 Joy Bhimji, BSP Manager, Drug Programs College of Physicians and Surgeons of British Columbia 2 http://www2.gov.bc.ca/assets/gov/health/about-bc-s-health-care-system/office-of-the-provincial-healthofficer/reports-publications/special-reports/bc-ost-system-measures-2013-2014.pdf
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-FIRST REGULAR SESSION April 24-26, 2017 Washington, D.C. OEA/Ser.L/XIV.2.61 CICAD/doc.2299/17 21 April 2017 Original: English CANADA S OPIOID
More informationPREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region
PREVENTING OPIATE OVERDOSES IN SCHOOLS Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region WHY IS THIS EVEN A QUESTION FOR SCHOOLS? In 2014, 467,000
More informationWEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT
WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT NOV 1 TO NOV 7, 215 REPORT WEEK 44 CANADA HUMANS During surveillance week 44, ending on Nov 7, 215, one (1) human clinical
More informationTITLE AUTHORS. Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy
TITLE Naloxone Counseling for Harm Reduction and Patient Engagement AUTHORS Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy Marianne E. Koenig, PharmD UPMC St. Margaret Family
More informationNaloxone for Emergency Administration: A 2017 Update On FDA Guidance
Naloxone for Emergency Administration: A 2017 Update On FDA Guidance Nathan A. Painter, PharmD, CDE Associate Clinical Professor University of California San Diego Skaggs School of Pharmacy and Pharmaceutical
More informationCOMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms
COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, 2018 2 Objectives: qreview names of different types of opioids qidentify the signs and symptoms
More informationSUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014
ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN
More information2017 JOB MARKET & EMPLOYMENT SURVEY EXECUTIVE SUMMARY
2017 JOB MARKET & EMPLOYMENT SURVEY EXECUTIVE SUMMARY Pay & Employment Rates The Canadian Dental Hygienists Association (CDHA) retained Framework Partners Inc. to conduct the 2017 Job Market and Employment
More information# Claims with disp.fee > 0. Average cost submitted by Rx**
QUEBEC SUMMARY REPORT QC Amount submitted (total) # Claims with disp.fee > 0 Average cost submitted by Rx** Average quantity per Rx Unit DIN cost submitted ALL PHARMACIES $540,947,952. 10,749,790 48.76
More informationNaloxone Distribution
Naloxone Distribution The Works, Toronto Public Health September 13, 2017 Web Conference Call Log-In: Name, Agency Name Mute computer speakers Telephone: 416-933-3851 Access code: 9373210 Mute/Unmute phone:
More informationHealth Canada Endorsed Important Safety Information on Infanrix Hexa
Health Canada Endorsed Important Safety Information on Infanrix Hexa October 30, 2012 Dear Health Care Professional: Subject: Voluntary recall of GlaxoSmithKline (GSK) Infanrix Hexa Vaccine Lot A21CB242A
More informationWe are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada
Programs & services Who we are Active in communities across Canada, the Alzheimer Society provides information, support and education to people living with Alzheimer s disease and other dementias. We are
More informationLaw Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health
Protecting, Leading, Uniting Since 1893 Law Enforcement Naloxone Training Florida Department of Children and Families Office of Substance Abuse and Mental Health 1. Learn how to recognize and respond to
More informationDrug Class Review: Opioid Reversal Agents
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationAPPENDIX: Key summary of six US-based naloxone distribution programs
Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States Traci C. Green, Robert Heimer, Lauretta
More informationNaloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative
Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid
More informationAchievements
Celebrating our Achievements 1999-2014 Executive summary www.canadianstrokenetwork.ca Celebrating our Achievements Canadian Stroke Network 1999-2014 Our mission was to reduce the impact of stroke on Canadians
More informationCanada s Inter agency Wild Bird Influenza Survey. Draft Proposal for the Survey Version 1 25 January 2010
Canada s Inter agency Wild Bird Influenza Survey Draft Proposal for the 2010 11 Survey Version 1 25 January 2010 Introduction Canada s wild bird influenza survey has been carried out each year since 2005.
More informationResponding to BC s Overdose Epidemic
Responding to BC s Overdose Epidemic Progress Update November/December 2017 BACKGROUND Since BC s Public Health Emergency was declared in 2016, people across the province have mobilized to immediately
More informationHarm Reduction Program Enhancement Questions and Answers. Population and Public Health Division Ministry of Health and Long-Term Care
Harm Reduction Program Enhancement Questions and Answers Population and Public Health Division Ministry of Health and Long-Term Care Table of Contents General Questions... 3 Funding... 4 Local Opioid Response...
More informationTechnology to support a Community of Practice Promoting Healthy Built Environment Policies
Technology to support a Community of Practice Promoting Healthy Built Environment Policies Kim Perrotta, HCBD Knowledge Translation & Communications Heart and Stroke Foundation Health Promotion Ontario
More informationvaccination in Canada Bernard Duval, md, mph, frcpc Institut National de Santé Publique du Québec Québec, Canada Sevilla,
Follow-up of hepatitis B vaccination in Canada Bernard Duval, md, mph, frcpc Institut National de Santé Publique du Québec Québec, Canada Sevilla, 2004-03 03-11 HB in Canada Low endemicity: HBsAg+ : 0.5%
More informationEstimating the volume of Contraband Sales of Tobacco in Canada
The Canadian Tobacco Market Place Estimating the volume of Contraband Sales of Tobacco in Canada Updated April 2010 Physicians for a Smoke-Free Canada 1226 A Wellington Street Ottawa, Ontario, K1Y 3A1
More information